Singh S, Shrivastava P, Agarwal A, Nandakumar K, Nasa V, Premkumar G
J Clin Exp Hepatol. 2023; 13(3):523-531.
PMID: 37250889
PMC: 10213854.
DOI: 10.1016/j.jceh.2022.12.012.
Koneti N, Bakhru S, Jayranganath M, Kappanayil M, Bobhate P, Srinivas L
Ann Pediatr Cardiol. 2022; 15(2):114-120.
PMID: 36246745
PMC: 9564419.
DOI: 10.4103/apc.apc_5_22.
Yin X, Shao Y, Zhang Y, Gao H, Qin T, Wen X
PeerJ. 2020; 8:e9243.
PMID: 32518736
PMC: 7261122.
DOI: 10.7717/peerj.9243.
Soulaidopoulos S, Goulis I, Cholongitas E
Ann Gastroenterol. 2020; 33(3):237-249.
PMID: 32382226
PMC: 7196609.
DOI: 10.20524/aog.2020.0474.
Sepehrinezhad A, Dehghanian A, Rafati A, Ketabchi F
BMC Cardiovasc Disord. 2020; 20(1):13.
PMID: 31931715
PMC: 6956555.
DOI: 10.1186/s12872-019-01297-z.
Onset ages of hepatopulmonary syndrome and pulmonary hypertension in patients with biliary atresia.
Ueno T, Saka R, Takama Y, Yamanaka H, Tazuke Y, Bessho K
Pediatr Surg Int. 2017; 33(10):1053-1057.
PMID: 28871319
DOI: 10.1007/s00383-017-4136-x.
Differential diagnosis of hepatopulmonary syndrome (HPS): Portopulmonary hypertension (PPH) and hereditary hemorrhagic telangiectasia (HHT).
Krynytska I, Marushchak M, Mikolenko A, Bob A, Smachylo I, Radetska L
Bosn J Basic Med Sci. 2017; 17(4):276-285.
PMID: 28759737
PMC: 5708897.
DOI: 10.17305/bjbms.2017.2020.
Pulmonary complications of hepatic diseases.
Surani S, Mendez Y, Anjum H, Varon J
World J Gastroenterol. 2016; 22(26):6008-15.
PMID: 27468192
PMC: 4948262.
DOI: 10.3748/wjg.v22.i26.6008.
Portopulmonary hypertension in liver transplant candidates.
Savas Bozbas S, Bozbas H
World J Gastroenterol. 2016; 22(6):2024-9.
PMID: 26877607
PMC: 4726675.
DOI: 10.3748/wjg.v22.i6.2024.
Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Portopulmonary hypertension.
Saleemi S, Idrees M
Ann Thorac Med. 2014; 9(Suppl 1):S42-6.
PMID: 25076996
PMC: 4114279.
DOI: 10.4103/1817-1737.134021.
Clinical manifestations of portal hypertension.
Al-Busafi S, McNabb-Baltar J, Farag A, Hilzenrat N
Int J Hepatol. 2012; 2012:203794.
PMID: 23024865
PMC: 3457672.
DOI: 10.1155/2012/203794.
Management of cardiopulmonary complications of cirrhosis.
Sawant P, Vashishtha C, Nasa M
Int J Hepatol. 2011; 2011:280569.
PMID: 21994850
PMC: 3170746.
DOI: 10.4061/2011/280569.
Evaluation of liver transplant candidates: A pulmonary perspective.
Savas Bozbas S, Eyuboglu F
Ann Thorac Med. 2011; 6(3):109-14.
PMID: 21760840
PMC: 3131751.
DOI: 10.4103/1817-1737.82436.
Successful treatment of portopulmonary hypertension with the selective endothelin receptor antagonist Sitaxentan.
Kahler C, Graziadei I, Vogelsinger H, Desole S, Cima K, Vogel W
Wien Klin Wochenschr. 2011; 123(7-8):248-52.
PMID: 21451953
DOI: 10.1007/s00508-011-1540-4.
Pulmonary complications of cirrhosis.
Kochar R, Nevah Rubin M, Fallon M
Curr Gastroenterol Rep. 2010; 13(1):34-9.
PMID: 21125431
DOI: 10.1007/s11894-010-0164-6.
Portopulmonary hypertension.
Saleemi S
Ann Thorac Med. 2010; 5(1):5-9.
PMID: 20351954
PMC: 2841810.
DOI: 10.4103/1817-1737.58953.
Hepatopulmonary syndrome and portopulmonary hypertension.
Hendrickse A, Azam F, Mandell M
Curr Treat Options Cardiovasc Med. 2007; 9(2):127-36.
PMID: 17484815
DOI: 10.1007/s11936-007-0006-5.
Portopulmonary hypertension.
Halank M, Ewert R, Seyfarth H, Hoeffken G
J Gastroenterol. 2006; 41(9):837-47.
PMID: 17048047
DOI: 10.1007/s00535-006-1879-x.
The extrahepatic consequences of cirrhosis.
Ho J, Yoshida E
MedGenMed. 2006; 8(1):59.
PMID: 16915189
PMC: 1681999.
Hepatopulmonary syndrome.
Arguedas M, Fallon M
Curr Treat Options Gastroenterol. 2005; 8(6):451-6.
PMID: 16313862
DOI: 10.1007/s11938-005-0031-y.